UBS Group’s Biote Corp. Warrant BTMDW Stock Holding History

UBS Group’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,830	Closed	-$2K	–	11472
2022 Q3	$2K	Sell	5,830 -3,750	-39%	-$1.22K	﹤0.01%	9854
2022 Q2	$4K	Buy	+9,580	New	+$5.17K	﹤0.01%	9211
2021 Q4	–	Sell	-94	Closed	–	–	10998
2021 Q3	$0	Buy	+94	New	+$84	﹤0.01%	10367

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

UBS Group's BTMDW Position: Q4 2022 in Review

UBS Group sold out of Biote Corp. Warrant (BTMDW) in Q4 2022, closing a stake of 5,830 shares — an estimated $2K sold.

UBS Group first reported a position in BTMDW in Q3 2021 and held it in 3 quarters. The position peaked at $4K in Q2 2022. 39 funds tracked by Wall St. Rank hold BTMDW as of Q4 2022.

UBS Group reported no remaining Biote Corp. Warrant position as of Q4 2022 after selling out during the quarter.
UBS Group sold 5,830 Biote Corp. Warrant shares in Q4 2022, an estimated $2K.
UBS Group first reported a position in Biote Corp. Warrant in Q3 2021 and held it in 3 quarters.
UBS Group's Biote Corp. Warrant position peaked at $4K in Q2 2022.
39 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.